Stock screener

VOR

Conviction 89HealthcareScan · Tue, Sep 8, 2026
VOR$25.03-0.08%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 714.68K
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Vor Biopharma Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.vorbio.com ↗
Price25.03
Change-0.08%
Gap-2.32%
Rel volume1.65×
Avg volume739.69K
Avg $ vol17.38M
SMA 2023.47
SMA 5021.37
SMA 20015.72
Price vs 50+17.12%
Price vs 200+59.24%
MA stackbullish
50/200 cross—
Supertrendup · 21.43
RSI (14)64
MACD hist0.02
MACD crossbull · 0d
Stoch %K / %D76 / 83
ADX (14)27
+DI / −DI30 / 14
RSI divergence—
MACD divergence—
ATR %+5.03%
ADR %4.76%
52w high48.72
52w low1.52
From 52w high-48.62%
Above 52w low+1546.71%
New 52w highNo
SqueezeOn · 9d
Bollinger width13.42%
%B1.00
Donchian pos76.81%
Donchian high26.02
Donchian low21.75
AVWAP (52w high)15.48
vs AVWAP high+61.65%
AVWAP (52w low)15.44
vs AVWAP low+62.15%
OBV trendFlat
Chaikin MF (20)0.09
Today vs 20d1.65×
Avg vol (14d)714.67K
Avg vol (20d)739.69K
Avg $ vol (20d)17.38M
Market cap—
RS 3m (vs SPY)+85.92%
RS 6m (vs SPY)+51.13%
RS line new highYes
Trend template7/8
Technical rank91.4
1 week+11.34%
1 month+5.75%
3 months+88.34%
6 months+61.90%
1 year+1177.04%
YTD+115.03%
P/E-2.13
P/B-7.39
P/S—
P/FCF-10.30
EPS-70.50
Div yield—
ROE347.65%
ROA-144.68%
Debt/Eq—
Current19.15
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-495.29%
Price target34.50
Target upside37.89%
Analyst ratingBuy
Institutional83.25%
Ent. value1.37B
Revenue—
Net income-62.81M
Gross profit—
Free cash flow-143.65M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out54.19M
Employees76
ListedFri, Feb 5, 2021
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA+
Conviction89 / 100
Pattern quality—
Tech rank91.4 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance24.44
Support17.52
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Setting up
    Aug 17 – Aug 19
    3 scans
  2. Breaking out now
    Sep 2
    1 scan

Recent news

Congress activity

Disclosed STOCK Act trades in VOR

All disclosures →
No recent disclosed trades by Congress in VOR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VOR · 2 buys · 8 sells

InsiderSideShares
RA CAPITAL MANAGEMENT, L.P.
10% owner · Stock Option (Right to Buy) · 2026-08-24
Exercise1.5K
RA CAPITAL MANAGEMENT, L.P.
10% owner · Common Stock · 2026-08-24
Exercise1.5K
ZACCARDELLI DAVID
Director · Stock Option (Right to Buy) · 2026-07-07
Grant42.66K
Kolchinsky Peter
Director · Common Stock · 2026-04-22
Sell165.15K
RA Capital Healthcare Fund LP
Director · Common Stock · 2026-04-22
Sell165.15K
RA CAPITAL MANAGEMENT, L.P.
Director · Common Stock · 2026-04-22
Sell165.15K
Shah Rajeev M.
Director · Common Stock · 2026-04-22
Sell165.15K
Shah Rajeev M.
Director · Common Stock · 2026-04-20
Sell171.96K
Kolchinsky Peter
Director · Common Stock · 2026-04-20
Sell171.96K
RA Capital Healthcare Fund LP
Director · Common Stock · 2026-04-20
Sell171.96K

SEC filings

EDGAR filings in VOR · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.